The National Institute of Biomedical Imaging and Bioengineering (NIBIB) released its Year in Review, the institute’s top science news of 2023. One review section — Biomedical Imaging Advances — discusses topics including combining ultrasound with artificial intelligence (AI) for cancer detection, an MRI contrast agent that targets hypoxic disease and a helmet with sensors to record brain function.
Also included is an interview between NIBIB and Maryellen Giger, PhD, a professor of radiology at the University of Chicago and the lead contact researcher, about how the Medical Imaging and Data Resource Center (MIDRC) can be used to develop and evaluate AI algorithms. MIDRC has collected images from nearly 55,000 patients, which has helped to create 27 in-house algorithms for the detection, diagnosis, monitoring and prognosis of COVID-19. MIDRC is co-led by investigators from the American College of Radiology® (ACR®), American Association of Physicists in Medicine and the Radiological Society of North America.
The National Institutes of Health (NIH) also recently released its 2023 Research Highlights, divided into three categories: Human Health Advances, Promising Medical Findings and Basic Research Insights.
ACR will continue to advocate for NIH and biomedical research agencies throughout 2024 to ensure discoveries and research progress.
For more information, contact Katie Grady, ACR Government Affairs Director.
ACR Presents to FDA on Oversight Considerations for GenAI Medical Devices
The ACR® presented at the U.S. FDA Digital Health Advisory Committee meeting “Total Product Lifecycle Considerations for Generative AI-Enabled Devices.” Bernardo Bizzo, MD, PhD, ACR Data Science Institute® Associate Chief Science Officer, represented the College at the meeting.
Read moreACR DSI Releases 2 New Non-Interpretive Reading Room Use Cases
use cases, artificial intelligence, reading room
Read moreDirect Supervision for Contrast Studies
We recommend that sites follow the ACR CT and MR Accreditation requirements for onsite supervision of contrast administration and management.
Read more